Font Size: a A A
Keyword [NKG2D]
Result: 161 - 177 | Page: 9 of 9
161. Regulation and genetic manipulation of ligands for the immunoreceptor NKG2D
162. The Transcriptional Mechanism Of TGF-?1 And The Immuno-suppressive Role Of Astilbin In NK1.1~-CD4~+NKG2D~+T Cells
163. Immune Evasive Property Of And Differentiation Therapy Against Cancer Stem Cells
164. Study On The Treatment Of Osteosarcoma With CXCL13-chemotactic CAR-T Cells And Its Mechanism
165. Research On NKG2D Mediated Cytotoxicity Of Allogeneic NK Cells Against Human Glioma Cells
166. The Immune-related Mechanism Underlying Enriched Environment-induced Tumor Growth Inhibition
167. Oncolytic Measles Virus Improves Antitumor Efficacy Of Adoptive CD8~+NKG2D~+ Cells Against Hepatocellular Carcinoma
168. Effect Of IL-21 On NKG2D+NK Cell Receptor Expression In Patients With Systemic Lupus Erythematosus
169. ATM Kinase Regulates Tumor Immunoreactions In Lymphocyte-predominant Breast Cancer Through Modulation Of NKG2D Ligand And TNF Cytokines On Tumor Cells
170. Expression And Clinical Significance Of NKG2D And SMICA In Dialysis Patients With End-stage Renal Disease
171. Study On Active Molecules That Promote Susceptibility Of Cancer Cells To NK Cell Mediated Cytolysis
172. Enhanced Effect Of NKG2D-CAR T Cells On The Treatment Of Pancreatic Cancer By Co-expressing IL-4R/IL-15R Chimeric Receptor
173. CUDC-101 Enhances The Cytotoxicity Of NK Cells In Vitro By Regulating The Expression Of NKG2DLs In Hepatocellular Carcinoma
174. The Establishment Of NKG2D CAR-NK Cells And Its Therapeutic Effect On Hepatocellular Carcinoma
175. Study On The Mesothelin And NKG2D Dual-Target Enhanced CAR-T In The Treatment Of Triple-Negative Breast Cancer
176. Ginsenoside Rh2 Interferes With ERp5,a SMICA-Related Protease,to Promote Tumor Immune Surveillance Of NK Cells
177. Soluble MULT1 Overexpressing In Mice And Its Effect On Liver Fibrosis Of Schistosomiasis Japonica
  <<First  <Prev  Next>  Last>>  Jump to